AMAG Pharmaceuticals, Inc has closed the previously announced divestiture of Cord Blood Registry (CBR) to GI Partners, a private equity investment firm, for US$ 530 million in an all cash sale. The purchase
Original Article: AMAG Pharma completes divestiture of Cord Blood Registry to GI Partners